Category Archives: Cancer Treatment

Eric Lefkofksy Is On A Mission

Eric Lefkofksy is changing the world through his innovation and his giving efforts. Lefkofksy and his wife Elizabeth Lefkofksy are the founders of the Lefkofksy Foundation. This is a foundation that has the desire to enhance the quality of human life. The foundation was established in 2006, and it purpose is to give funding to programs that have a high impact on humanity. This is a foundation that endeavors to improve human rights, propel innovation, and expand access to quality education. This is a foundation that also gives grants to education by supporting and strengthening public schools and promoting advanced education for all income levels. The Lefkofksy Foundation also gives grants to medical research. Elizabeth and Eric Lefkofksy want to continue to give funds to medical research; this is research that can prevent and cure diseases. The Lefkofksy Foundation is also a huge supporter of arts and culture. This foundation gives grants to various art programs, and it promotes creativity and cultural enrichment in local communities.

Eric Lefkofksy is the co-chair of the Lefkofksy Family Foundation, and he is also the founder and CEO of Tempus. Tempus is a medical technology company that is remarkable. The goal of Tempus technology is to fight against all types of cancer. This technology allows physicians to look at their patient’s DNA on a molecular level. By examining the molecules of each and every patient, Tempus is able to tailor make specific treatments that can help their patients get relief from can cancer.

Lefkofksy is also the cofounder and president of Groupon. Groupon is a very well-known online commerce company, and it is frequently traded on the NASDAQ; Groupon is a company that has grossed millions of dollars since its inception. Many individuals buy from the Groupon’s website, and they are able to save themselves hundreds of dollars on entertainment, technology, clothing and more.Eric Lefkofksy is an individual who has diversified himself in amazing ways. He believes in the importance of giving back to the community and also in the importance of continual learning.

Clay Siegall Develops Modernized Therapies for Cancer Treatment


Being one of the world’s primary medical problems, cancer has attracted many scientists and physicians globally. The core objective of these doctors is finding treatment. One of the scientists who has made a name for themselves in the field of cancer research center and treatment is Clay Siegall. Following his strong academic background and research, Clay Siegall has significantly contributed to the fight against all types of cancer. Dr. Clay Siegall is the co-founder of Seattle Genetics; an emerging biotech company focused on revolutionizing cancer treatment across the world. He is a scientist by training and since 1998; he has been Seattle Genetics’ President and Chief Executive Officer. Clay is also Chairman of the board.

Seattle Genetics

Seattle Genetics emphasizes on modernized cancer therapies. It was established from scientific innovation, extensive research and drug generation practices aimed at assisting patients. Through Clay’s leadership, Seattle Genetics has been able to provide antibody-drug conjugates for cancer therapies. Additionally, the cancer research center has been able to secure an approval of the 2011 FDA, ADC product. Following its collaboration with Takeda Pharmaceutical, Seattle Genetics managed to introduce ADCETRIS brand into the market, for further treatment in cancer. Over 65 countries have the approval of ADCETRIS. Seattle Genetics commits to advancing an extensive channel of proprietary ADCs for cancer treatment.

Clay Siegall’s’ Contribution

With the contribution of Dr. Siegall, Seattle Genetics has been able to enter into several strategic licenses linked to ADC. It has also collaborated with Genentech, GlaxoSmithKline (Gsk), Pfizer and AbbVie in the fight against cancer. Bordering international programs, over 20 ADCs have been linked to clinical development procedures in cancer treatment. Additionally, Dr. Clay Siegall has geared Seattle Genetics resources to secure over $1.2 billion in public and private money lending institutions.

About Clay Siegall

Clay is the President and Chief Executive Officer of Seattle Genetics. He attended the University of Maryland and graduated with a bachelor’s degree in Science, having majored in Zoology. Clay advanced his knowledge and skills in the University of George Washington. He studied Genetics before joining the cancer research center.